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Objective To determine the quantitative variances in peripheral blood lymphocyte
subsets during sepsis, and their clinical signiﬁcance.
Methods Peripheral blood lymphocyte subsets were enumerated in 32 non-surgical
septic patients during the ﬁrst 14 days of hospitalization; results from septic patients were
compared with those from 34 healthy controls. Inﬂuences of the severity and the bacterial
etiology of sepsis on changes in lymphocyte subsets were also assessed.
Results Signiﬁcant decreases (P< 0.05) from normal values of CD4þ, CD8þ and total T-
lymphocytes were observed in septic patients, but the decline persisted only for CD4þ T-
lymphocytes and natural killer (NK) cells for 3 and 7days, respectively. In addition, the
numbers of CD3þ/DRþ lymphocytes were signiﬁcantly elevated on day 14. There were
no correlations between these alterations and the severity of sepsis. Gram-positive sepsis
(n¼ 10), which was mainly due to Streptococcus pneumoniae and Staphylococcus aureus,
caused prolonged decreases in CD4þ, CD8þ and total T-lymphocytes, and a reduction in
NK cells, that lasted for14days. Conversely, patients with sepsis due to Gram-negative
pathogens (Neisseria meningitidis, n¼ 8; enterobacteria, n¼ 2) achieved full recovery of the
subsets within 3days. Moreover, the patients with Gram-negative sepsis demonstrated a
signiﬁcant increase in B-lymphocytes, and a rise in the numbers of CD3þ/DRþ and CD4þ
T-lymphocytes, which were more rapid than in patients with Gram-positive sepsis.
Conclusion Our results indicate that Gram-positive sepsis causes stronger suppression
of peripheral blood lymphocyte subsets in comparison to sepsis due to Gram-negative
pathogens.
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INTRODUCTION
Sepsis is an important microbial disease, with an
annual incidence recently estimated to be more
than 750 000 cases, contributing to 215 000 deaths
per year in the USA [1]. The pathophysiology of
sepsis is characterized by a systemic host response
to microorganisms or their signal molecules (e.g.
endotoxin) entering the bloodstream [2]. Sepsis-
induced systemic inﬂammatory responses are con-
trolled by contra-inﬂammatory mechanisms,
which prevent organ injury due to exaggerated
systemic inﬂammation. However, the contra-
inﬂammatory responses may cause suppression
of immune responses, leading to secondary infec-
tions [3]. Although complement and antibodies
play an important role in the septic response,
innate immunity and adaptive cell-mediated
immunity (CMI) are probably the most sup-
pressed immune functions during sepsis. The
immunosuppressive effects of sepsis on innate
immunity comprise reduced phagocytosis,
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decreased pro-inﬂammatory cytokine production
and antigenic presentation by monocytes–macro-
phages, decreased adhesion, migration and oxida-
tive burst of neutrophils, as well as reduced
numbers of circulating natural killer (NK) cells
[4–7]. Reductions in circulating CD4þ T-lympho-
cytes and their shift to a Th2 phenotype character-
ize aspects of sepsis-induced suppression of
adaptive CMI [8]. Interestingly, sepsis can also
elicit profound depletion of B-lymphocytes as well
as CD4þ T-lymphocytes in secondary lymphoid
organs, which may contribute to a decreased abil-
ity to combat infection [9]. The associations
between complicated clinical course or unfavor-
able prognosis of septic patients with the decline of
peripheral blood (PB) CD4þ T-lymphocytes and
activated T-lymphocytes (CD3þ/DRþ) were estab-
lished in a majority of trauma victims or surgical
patients with secondary sepsis [10,11]. A study
performed by Williams et al. [12] on 31 non-surgi-
cal septic patients demonstrated no predictive
value of T-lymphocyte abnormalities, although
only four septic patients were examined longitud-
inally, and two patients with irreversible sepsis
showed a persistent decrease in numbers of circu-
lating T-lymphocytes.
The aim of the present study was to conduct
longitudinal characterization of circulating lym-
phocyte subsets in non-surgical septic patients
during the 2 weeks following onset of sepsis.
The relationship of lymphocyte subset kinetics
to the clinical course and bacterial origin of sepsis
was also assessed.
PATIENTS AND METHODS
Patients
The prospective study was conducted in accor-
dance with the Helsinki Declaration after obtain-
ing institutional review board approval during the
period from September 1998 to March 2000.
Thirty-two consecutive septic patients (16 females
and 16 males, mean age 32.9 years, range 10–
78 years) admitted to the Department of Infectious
Diseases of the University Hospital Bulovka, Pra-
gue, Czech Republic were enrolled into the study.
Sepsis was diagnosed according to the ACCP/
SCCM Consensus Conference as systemic inﬂam-
matory response syndrome (SIRS) with an infec-
tion [13]. All patients had tomeet at least two of the
following criteria for SIRS: (1) temperature above
38 8C or below 36 8C; (2) heart rate above 90 beats/
min; (3) respiratory rate above 20 breaths/min or
PaCO2< 32mmHg; and (4) leukocytosis above
12 109/L or leukopenia below 4 109/L, or more
than 10% band forms on a blood ﬁlm, as well as the
presence of infection. Infection was documented
by the isolation of pathogenic bacteria from the
blood or from other normally sterile sites. In addi-
tion, infection in patients without positive cultures
was diagnosed clinically, and patients received
empirical antibiotic treatment. Exclusion criteria
included age below 10 years and above 80 years,
treatment with immunomodulating therapy,
HIV/AIDS,malignant disorder, surgery or trauma
related to the presenting illness, and an interval
between the onset of clinical symptoms of the
disease and admission of more than 24 h. The
control group consisted of 34 age- and gender-
matched healthy persons.
Patients were followed for 14 days from the day
of admission. The severity of the illness was
assessed on admission according to the APACHE
II score (Acute Physiologic and Chronic Health
Evaluation) [14]. For the assessment of the clinical
course of sepsis, we used the SOFA score (Sequen-
tial Organ Failure Assessment), C-reactive protein
(CRP) plasma levels, and leukocytosis [2,15,16].
Two patients died during the study; the causes
of their deaths were non-septic (malign arrhyth-
mia and brain edema). An overview of patients’
demographics, clinical diagnoses and laboratory
ﬁndings is given in Table 1. In addition, microbio-
logical follow-up was routinely performed for all
patients admitted to the intensive care unit as well
as patients with indwelling catheters hospitalized
in standard wards. During the study, eight
patients were diagnosed as having a nosocomial
infection. There were 10 episodes of nosocomial
infections (three cases of pneumonia, four urinary
tract infections, and three cases of catheter-related
sepsis) documented with an onset between 7 and
10days after admission to the hospital.
Analysis of the inﬂuence of bacterial origin of
sepsis utilized data from patients with an estab-
lisheddeﬁnitive etiologicdiagnosis of sepsis,which
requires the isolation of microorganisms from the
blood and/or from a local site of infection [2].
Bacterial pathogens were isolated from blood
and/or cerebrospinal ﬂuid (CSF), and patients
withpositiveﬁndingsweredividedintotwogroups:
(1) Gram-positive sepsis due to Streptococcus pneu-
moniae (n¼ 6), Staphylococcus aureus (n¼ 3), or vir-
idans streptococci (n¼ 1); and (2) Gram-negative
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sepsis caused by Neisseria meningitidis (n¼ 8),
Escherichia coli (n¼ 1), or Proteus mirabilis (n¼ 1).
An overview of the demographic and clinical data
on these patients is presented in Table 2.
Laboratory methods
Blood samples were drawn in K-3 EDTA Vacutai-
ner tubes (Becton-Dickinson, San Jose, CA,USA) at
baseline (day 0) in all patients enrolled into the
study; additional samples were drawn at 3, 7 and
14 days after admission. White cell counts (Coulter
STKS, Coulter Electronics Inc., Miami, FL, USA)
and Wright-stained microscope differential leuko-
cyte counts were performed to calculate the abso-
lute number of leukocytes, lymphocytes and
lymphocyte subsets per cubic millimeter of blood.
Lymphocyte subsets in the blood were investi-
gated using monoclonal antibodies and ﬂow
cytometry. PB lymphocyte subsets included total
T-lymphocytes (CD3þ), CD4þ T-lymphocytes
(CD3þCD4þ), CD8þ T-lymphocytes (CD3þCD8þ),
total B-lymphocytes (CD19þ), NK cells (CD3–
CD16þ and CD56þ), and CD3þ/DRþ lymphocytes
(CD3þ/anti-HLA-DRþ). Immunophenotypingwas
done by two-color ﬂow cytometric analysis (FAC-
Strak or FACScalibur with Simulset software, Bec-
ton Dickinson Immunocytometry Systems, San
Jose, CA, USA) using IMK-Lymphocyte Kit of
monoclonal antibodies (containing Leukogate, Iso-
type Control, CD3/CD19, CD3/CD4, CD3/CD8,
CD3/CD16þ56 and CD3/anti-HLA-DR; Becton
Dickinson, Heildelberg, Germany). The CD4/
CD8 ratio was counted as the percentage of
CD4þ T-lymphocytes divided by the percentage
of CD8þ T-lymphocytes. This protocol is routinely
used in the laboratory and undergoes a periodic
evaluation in the international quality assurance
scheme CEQUAL [17]. CRP plasma levels were
measured with a nephelometer (Behring, Vienna,
Austria) using set Latex CRPMono (Behring) with
a normal range between 0 and 8mg/L.
Statistical analysis
Absolute numbers of leukocytes, lymphocytes and
lymphocyte subsets were comparedwith the refer-
ence values obtained from the control group by
one-way ANOVA and Dunn’s method or Tukey’s
test. These statistical analyses were also used to
test intergroup differences in regard to the bacter-
ial origin of sepsis. Spearman correlation and lin-
ear regression were utilized for analysis of the
inﬂuence of APACHE II, SOFA and CRP plasma
levels on lymphocyte subset numbers. The a level
of 0.05 was considered statistically signiﬁcant. The
data are presented, if not stated otherwise, as
mean standard error (SE).
RESULTS
Kinetics of numbers of white blood cells and
circulating lymphocytes
On admission, when compared with healthy con-
trols, septic patients had signiﬁcantly higher
values of absolute numbers of blood leukocytes
Table 2 Demographics, clinical characteristics and laboratory findings of patients with sepsis due to Gram-positive or
Gram-negative pathogens
Characteristics
Gram-negative sepsis
(n¼ 10)
Gram-positive sepsis
(n¼ 10)
Student’s
t-test
Age, mean (years) 25.8 4.8 42.3 6.9 NS
Sex, female/male 6/4 3/7 NSa
Scores at admission
APACHE II 15.7 3.6 17.7 3.0 NS
SOFA 4.1 1.2 6.3 1.7 NS
Outcome, recovered/died 10/0 8/2b NSa
Hospitalization (days) 24.3 4.8 30.6 6.9 NS
ICU/standard ward (number of patients) 7/3 7/3 NSa
Laboratory findings on admission
WBC (109 cells/L) 22.2 3.4 18.0 1.5 NS
CRP (mg/L) 317.4 37.8 389.0 53.9 NS
NS, non-significant (an a level 0.05 is considered statistically significant); WBC, white blood cells.
aEmployed Fisher’s exact test.
bOverall mortality (one patient died after the study).
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(20.5 1.5 versus 6.8 0.3 cells/mm3, P< 0.05).
Although this level decreased after admission,
signiﬁcant leukocytosis persisted after 3 days
(14.4 1.5 cells/mm3, P< 0.05) and 7days
(12.5 1.2 cells/mm3, P< 0.05) of hospitalization.
In contrast, the absolute numbers of circulating
lymphocytes were reduced signiﬁcantly only at
admission (0.9 0.1 versus 2.0 0.1 cells/mm3,
P< 0.05), and normalized thereafter. This recovery
of circulating lymphocytes was delayed with
Gram-positive sepsis. Three days after admission,
the decline in lymphocyte counts still persisted
(1229 205 cells/mm3, P< 0.05).
Kinetics of lymphocyte subset numbers
(Figure 1)
The absolute numbers of total T-lymphocytes,
when compared with values obtained from
healthy controls, showed a marked drop from
the norm (505 80 versus 1435 116 cells/mm3,
P< 0.05). As with the absolute lymphocyte count,
the initial depression was followed by rapid recov-
ery of circulating total T-lymphocytes. In patients
with Gram-positive sepsis, reductions in the num-
bers of total T-lymphocytes were still apparent
after 3 days of hospitalization (757 142 cells/
mm3, P< 0.05).
A similar course was observed for the absolute
numbers of CD4þ T-lymphocytes. After the initial
reduction (287 28 versus 936 62 cells/mm3,
P< 0.05), the CD4þ T-lymphopenia was followed
by a rapid and steady rise, but 3 days after admis-
sion there was still a signiﬁcant decrease in the
absolute numbers of CD4þ T-lymphocytes
(684 96 cells/mm3, P< 0.05). This persistent
reduction was more evident with Gram-positive
sepsis (520 104 cells/mm3, P< 0.05); patients
with sepsis due to Gram-negative pathogens
achieved full recovery of this subset by 3 days after
admission. Moreover, the numbers of CD4þ
T-lymphocytes in the blood of septic patients with
Gram-negative sepsis showed a trend for an
increase above the norm. This rise was signiﬁcant
when compared with data obtained from patients
with Gram-positive sepsis at day 7 (1359 273
versus 672 107 cells/mm3, P< 0.05) and day 14
(1214 200 versus 748 121 cells/mm3, P< 0.05)
(Figure 2a).
The changes in circulating CD8þ T-lymphocytes
were parallel to the kinetics of changes in the
absolute numbers of total T-lymphocytes. There
was a signiﬁcant decrease in the absolute numbers
of CD8þ T-lymphocytes after admission (251 60
versus 499 33 cells/mm3, P< 0.05), and recovery
was achieved by day 3. Gram-positive sepsis was
responsible for a slower recovery of circulating
CD8þ T-lymphocytes: the signiﬁcant fall in this
subset still persisted after 3 days of hospitalization
(166 55 cells/mm3, P< 0.05).
Circulating NK cells were also signiﬁcantly
reduced in septic patients (181 35 versus
330 30 cells/mm3, P< 0.05). The absolute num-
bers of circulating NK cells did not rise over time
and were signiﬁcantly lower at 3 days (190 20
cells/mm3, P< 0.05) and 7days (186 18 cells/
Figure 1 Kinetics of circulating total
T-lymphocytes, CD4þ T-lympho-
cytes, CD8þ T-lymphocytes, CD3þ/
DRþ lymphocytes and NK cells in
septic patients compared with va-
lues from healthy controls. Statisti-
cally significant differences (P< 0.05)
between septic patients and healthy
controls.
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mm3, P< 0.05) after admission. Although their
absolute numbers on day 14 were not statistically
different from those of healthy controls, the trend
for recovery was less apparent than for total T-
lymphocytes. Interestingly, the numbers of circu-
latingNK cells were signiﬁcantly reduced on day 3
(150 31 cells/mm3, P< 0.05), day 7 (145 35
cells/mm3, P< 0.05) and day 14 (177 63 cells/
mm3, P< 0.05) only with Gram-positive sepsis.
Conversely, patients with sepsis caused by
Gram-negative pathogens showed no signiﬁcant
differences in this subset after 3 days of hospitali-
zation (Figure 2b).
The numbers of circulating B-lymphocytes in
septic patients when compared with values
obtained from healthy controls did not show sig-
niﬁcant changes (data not shown). Interestingly,
sepsis due to Gram-negative pathogens was
responsible for signiﬁcant increases in the num-
bers of B-cells on day 3 (479 55 versus 314 32
cells/mm3, P< 0.05) and day 7 (587 128 cells/
mm3, P< 0.05). A similar trend was also observed
with Gram-positive sepsis, but this increase was
not signiﬁcant (Figure 2c).
From the day of admission until 7 days after
hospitalization, the absolute number of CD3þ/
DRþ lymphocytes was not signiﬁcantly changed
when compared to healthy controls: however, an
increase was observed after 14 days of hospitaliza-
tion (318 54 versus 107 17 cells/mm3, P< 0.05).
This increase was more rapid with sepsis due to
Gram-negative pathogens. The numbers of circu-
lating CD3þ/DRþ lymphocytes were signiﬁcantly
higher than values obtained from patients with
Gram-positive sepsis (291 72 versus 184 101
cells/mm3, P< 0.05) or from healthy controls by
day 7 (Figure 2d).
The CD4/CD8 ratios were not signiﬁcantly
changed, and there were no correlations between
lymphocyte subset numbers with APACHE II and
SOFA scores or CRP plasma levels of the septic
patients or patients with an established etiologic
Figure 2 Kinetics of circulating CD4þ T-lymphocytes (a), NK cells (b), B-lymphocytes (c) and CD3þ/DRþ lymphocytes (d)
in patients with Gram-positive sepsis and sepsis due to Gram-negative pathogens. Significant differences (P< 0.05) from
healthy controls; hash signs indicate significant difference (P< 0.05) between Gram-positive and Gram-negative sepsis.
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diagnosis of sepsis at any given point (data not
shown). In addition, there was a signiﬁcant
negative correlation of the incidence of the noso-
comial infections with reduced numbers of circu-
lating B-lymphocytes on day 3 (P¼ 0.04, r¼0.39)
and day 7 (P¼ 0.02, r¼0.442).
DISCUSSION
The most affected lymphocyte subsets in our
group of septic patients were NK cells (Figure
1). These immune cells are important components
of innate immunity; they do not require antigen-
speciﬁc stimulation, and represent part of the ﬁrst
line of host defense [18]. The observed persistent
reduction in the numbers of circulating NK cells
might reﬂect their pronounced activation and
intense trafﬁcking into tissues during the initial
stage of sepsis [19]. The protective effect of NK
cells against infections comprises rapid produc-
tion of interferon (IFN)-g, contributing to intracel-
lular killing of bacteria and the ability to destroy
antibody-coated pathogens by a process called
antibody-dependent cell-mediated cytotoxicity
as well as perforin-mediated cytolysis or apoptosis
(programmed cell death) of MHC class I negative
cells [18,20–23]. Interestingly, the decrease in the
numbers of NK cells observed during the study
was inﬂuenced by the bacterial origin of sepsis.
Patients with Gram-positive sepsis demonstrated
a more persistent reduction in the numbers of
circulating NK cells than that seen with Gram-
negative sepsis (Figure 2b). This might indicate
very intense activation of NK cells during severe
Gram-positive infection, whose elimination
usually requires highly organized host responses,
whereas many Gram-negative pathogens are efﬁ-
ciently destroyed by complement and antibodies
[24]. After activation, NK cells can be eliminated
by apoptosis to prevent excessive production of
IFN-g, which may, in turn, cause an exaggerated
activation of monocytes and massive release of
pro-inﬂammatory cytokines such as interleukin-
1b and tumor necrosis factor (TNF)-a [25,26]. On
the other hand, excessive apoptosis of NK cells
also may lead to persistent reduction in their
circulating numbers, which has been shown to
be an important sign of immunosuppression pre-
disposing trauma victims to secondary bacterial
infections [27].
Signiﬁcant reductions in circulating T-lympho-
cytes and their respective subsets observed during
the acute phase of sepsis were transient (Figure 1)
and independent of the severity of the illness.
Although the loss of lymphocytes in sepsis is often
considered to be due to apoptosis [9], rapid recov-
ery of total, CD4þ and CD8þ T-lymphocytes could
also indicate their intense trafﬁcking between tis-
sues and the lymphatic system during the acute
phase of the illness [28]. Reductions in circulating
CD4þ and CD8þ T-lymphocytes also could be
elicited by release of high amounts of endogenous
corticosteroids or TNF-a, which are raised due to a
stress response in the early stage of severe bacterial
infections and sepsis [29–32]. Interestingly, in ani-
mal experiments, it has been documented that
changes in lymphocyte subset distribution are
reversed swiftly after the cessation of stress [16].
In our study, broad-spectrum antibiotics sup-
pressed bacterial infection in all septic patients
by day 3, as was documented by the signiﬁcant
decrease in CRP plasma level (data not shown),
which is considered a good indicator of the resolu-
tion of sepsis [33]. Therefore, rapid normalization
of the absolute numbers of circulating CD4þ and
CD8þ T-lymphocytes in patients enrolled in the
study is, in our opinion, caused by suppression
of bacterial growth and cessation of bacterial
stress.
Interestingly, the patterns of the recovery of
circulating total T-lymphocytes and their respec-
tive subsets were dependent upon the bacterial
etiology of sepsis. Rapid normalization of the
numbers of T-lymphocytes and their subsets in
the blood, and especially the trend for the increase
in the numbers of PB CD4þ T-lymphocytes above
the norm, were characteristic for sepsis caused by
Gram-negative pathogens (Figure 2a). N. menigi-
tidis was the prevailing etiologic agent of the
Gram-negative sepsis, and some meningococcal
antigens can stimulate CD4þ T-lymphocyte pro-
liferation [34]. However, two patients had Gram-
negative sepsis due to enterobacteria (P. mirabilis
and E. coli), and they showed similar trends as
patients with meningococcal sepsis, with high
numbers of PB CD4þ T-lymphocytes on days 7
and 14. The primary role in the pathogenesis of
Gram-negative sepsis has been assigned to endo-
toxin [24]. Endotoxin can synergize with antigenic
peptides and increase proliferation of T-lympho-
cytes [35], which may be followed by their accu-
mulation in the blood. Although S. aureus and S.
pneumoniae (the prevailing etiologic agents in
patients with Gram-positive sepsis) have been
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shown to cause early polyclonal activation of T-
lymphocytes [36,37], the increase in the numbers
of circulating CD4þ T-lymphocytes was signiﬁ-
cantly less than that observed with Gram-negative
sepsis. This could be due to activation-induced cell
death (AICD) of those activated T-lymphocytes in
the tissues [38]. Thus, AICDmight be an important
mechanism responsible for slow recovery of cir-
culating CD4þ T-lymphocytes in patients with
Gram-positive sepsis.
The marked increase in the numbers of circu-
lating B-lymphocytes with sepsis caused by
Gram-negative pathogens and the trend for their
numbers to rise above the norm in patients with
Gram-positive sepsis on day 3 and day 7 (Figure
2c) may represent the transition from innate to
more speciﬁc adaptive immune responses. The
increase in the numbers of circulating B-lympho-
cytes in patients with Gram-negative sepsis was
similar to the increase in CD4þ T-lymphocytes,
and this ﬁnding was apparent regardless of the
Gram-negative etiology of the illness. Signiﬁcant
accumulation of B-lymphocytes in the blood of
patients recovering from Gram-negative sepsis
might represent intensive B-lymphocyte prolifera-
tion due to enhanced T–B-lymphocyte cooperation
[18]. Conversely, S. aureus and S. pneumoniae could
be directly responsible for the trend in the increase
of PB B-lymphocyte numbers above the norm
observed in patients recovering from Gram-posi-
tive sepsis, as both pathogenswere documented as
being polyclonal activators of B-lymphocytes [39].
Aswas shown in an animalmodel of sepsis elicited
by parasitic infection, the proliferation of B-lym-
phocytes takes place in the spleen and may be
subsequently followed by their appearance in the
blood [40]. In addition, signiﬁcant correlation of
reduced numbers of B-lymphocytes on days 3 and
7 with the incidence of nosocomial infection in our
patients might suggest the importance of this sub-
set as a clinical marker of sepsis-induced immu-
nosuppression. However, bacterial etiology (data
not shown) and the sites of nosocomial infections
were considerably different, which complicates
evaluation of the ﬁnding in relatively small num-
bers of patients.
Non-surgical septic patients, when compared to
control subjects, showed no signiﬁcant change in
numbers of circulating CD3þ/DRþ lymphocytes
[41], which is compatible with our observations
during the ﬁrst week of non-surgical sepsis.
However, the numbers of circulating CD3þ/DRþ
lymphocytes signiﬁcantly rose in our patients on
day 14 (Figure 1), probably reﬂecting late lympho-
cyteactivationanddevelopmentof speciﬁc immune
responses [42]. Interestingly, a slower rise in the
numbers of circulating CD3þ/DRþ lymphocytes,
which was observed with Gram-positive sepsis
when compared to a more rapid increase in this
subset in patients with Gram-negative sepsis
(Figure 2d), may indicate a delay in the adaptive
immune reactions during severe Gram-positive
infection. In addition, two patients who died dur-
ing the study demonstrated low numbers of PB
CD3þ/DRþ lymphocytes and NK cells before
death (data not shown). Both persons succumbed
to non-septic complications after resolution of
sepsis, and the numbers of CD4þ and CD8þ T-
lymphocytes aswell as B-lymphocytes in the blood
rose over time. The decrease in the numbers of PB
CD3þ/DRþ lymphocytes andNK cells observed in
the non-survivors might suggest a high sensitivity
of these subsets to stress conditions.
In conclusion, our results indicate that sepsis-
induced decreases in lymphocyte subsets in the
blood are independent of the severity but not the
bacterial etiology of the illness. However, whether
these differences only reﬂect speciﬁc host res-
ponses to certain pathogens or also play a role
in the pathophysiology of sepsis needs to be clar-
iﬁed.
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